Form 4: Hims & Hers Health Chief Commercial Officer Executes Stock Option and Sells Shares

Michael Chi, Chief Commercial Officer of Hims & Hers Health, exercised stock options and sold shares on November 19, 2024, according to a recent SEC filing.

Summary

• Michael Chi, the Chief Commercial Officer of Hims & Hers Health, executed a stock option to acquire 7,500 shares of Class A Common Stock at a price of $13.90 per share on November 19, 2024.
• Concurrently, Mr. Chi sold 7,500 shares of Class A Common Stock at a price of $22.00 per share on the same day.
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 1, 2024.
• Following these transactions, Mr. Chi directly owns 183,980 shares of Class A Common Stock and 59,082 stock options.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing insider transactions, which is neither positive nor negative in itself. The transactions were pre-planned and expected.

Industry Context

This filing is a routine disclosure of insider transactions and is common for publicly traded companies. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

• The use of a Rule 10b5-1 trading plan is a common practice among executives at publicly traded companies to avoid accusations of insider trading.
• The reported transactions are typical for executives who receive stock options as part of their compensation package.
• Similar filings are regularly made by executives at comparable companies such as Teladoc Health and GoodRx.

Stakeholder Impact

• The transactions may have a minor impact on the stock price, but are unlikely to cause significant fluctuations as they were pre-planned.
• Shareholders are informed of insider trading activity, which promotes transparency.

Key Dates

Keywords

stock options, insider trading, SEC Form 4, Hims & Hers Health, Rule 10b5-1, equity securities, Michael Chi, Chief Commercial Officer